For research use only. Not for therapeutic Use.
FTY720 is a novel immune modulator that prolongs allograft transplant survival in numerous models by inhibiting lymphocyte emigration from lymphoid organs. FTY720 is phosphorylated by sphingosine kinases <em>in vivo</em>, and then acts as a potent agonist at four of the five sphingosine-<wbr></wbr>1-<wbr></wbr>phosphate (S1P) receptors. FTY720 (S)-<wbr></wbr>phosphate is the single stereoisomer formed by phosphorylation of FTY720 <em>in vivo</em>, as determined in rats and humans. It exhibits K<sub>i</sub> values of 2.1, 5.9, 23, and 2.2 nM for S1P<sub>1</sub>,<sub>3</sub>,<sub>4</sub>,<sub>5</sub>, respectively, whereas the R enantiomer binds with 5 to 130-<wbr></wbr>fold lower affinity. FTY720 (S)-<wbr></wbr>phosphate causes internalization of S1P<sub>1</sub> on lymphocytes, abrogating S1P-<wbr></wbr>dependent egress of lymphocytes from lymphoid organs. It also enhances endothelial barrier function, stimulates the activity of the sphingosine transporter Abcb1 and the leukotriene C<sub>4</sub> transporter Abcc1 and inhibits cytosolic phospholipase A<sub>2</sub> activity.
Catalog Number | R006910 |
CAS Number | 402616-26-6 |
Synonyms | 2-(S)-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol Mono(dihydrogen phosphate) Ester; (S)-FTY720-P; (S)-Fingolimod |
Molecular Formula | C19H34NO5P |
Purity | ≥95% |
Target | LPL Receptor |
Storage | -20°C |
IUPAC Name | [(2S)-2-amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl] dihydrogen phosphate |
InChI | InChI=1S/C19H34NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21H,2-8,13-16,20H2,1H3,(H2,22,23,24)/t19-/m0/s1 |
InChIKey | LRFKWQGGENFBFO-IBGZPJMESA-N |
SMILES | CCCCCCCCC1=CC=C(C=C1)CCC(CO)(COP(=O)(O)O)N |